Boron-containing folate receptor-targeted liposomes as potential delivery agents for neutron capture therapy

Bioconjugate Chemistry

Volumn 13, Issue 3, 2002, Pages 435-442

  Pan, Xing Q ^a   Wang, Huaqing ^a   Shukla, Supriya ^a   Sekido, Masaru ^a   Adams, Dianne M ^a   Tjarks, Werner ^a   Barth, Rolf F ^a   Lee, Robert J ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; CYTOLOGY; EFFICIENCY; ENCAPSULATION; LOADING; NITROGEN COMPOUNDS; SODIUM COMPOUNDS; SULFUR COMPOUNDS; TARGETED DRUG DELIVERY; TUMORS;

B ATOMS; BORON NEUTRON CAPTURE THERAPY; BORON NEUTRONCAPTURE THERAPY; BORON-CONTAINING; FOLATE RECEPTOR; LOADING EFFICIENCY; NEUTRON CAPTURE THERAPY; SPERMIDINE; TRAPPING AGENT; TUMOUR CELLS;

LIPOSOMES;

BORON DERIVATIVE; CARRIER PROTEIN; CELL SURFACE RECEPTOR; FOLATE BINDING PROTEIN; FOLATE-BINDING PROTEIN; LIPOSOME; SPERMIDINE;

ARTICLE; CELL STRAIN KB; CHEMISTRY; DRUG DELIVERY SYSTEM; DRUG EFFECT; HUMAN; METABOLISM; METHODOLOGY; NEUTRON CAPTURE THERAPY;

BORON COMPOUNDS; BORON NEUTRON CAPTURE THERAPY; CARRIER PROTEINS; DRUG DELIVERY SYSTEMS; HUMANS; KB CELLS; LIPOSOMES; RECEPTORS, CELL SURFACE; SPERMIDINE;

EID: 0036000119     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc015557y     Document Type: Article

References (49)

1. Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo
2. Folate receptors
3. Determination of boron in tissues and cells using direct-current plasma atomic emission spectroscopy
4. Boron neutron capture therapy of brain tumors: An emerging therapeutic modality
5. Boron neutron capture therapy of brain tumors: Enhanced survival and cure following blood-brain barrier disruption and intracarotid injection of sodium borocaptate and boronophenylalanine
6. Boron neutron capture therapy of brain tumors: Enhanced survival following intracarotid injection of either sodium borocaptate or boronophenylalanine with or without blood-brain barrier disruption
7. New sterically stabilized vesicles based on nonionic surfactant, cholesterol, and poly(ethylene glycol)-cholesterol conjugates
8. Boron-containing polyamines as DNA targeting agents for neutron capture therapy of brain tumors: Synthesis and biological evaluation
9. 99mTc and in vivo localization following intracerebral injection into normal and glioma bearing mice
10. Boronated epidermal growth factor as a potential targeting agent for boron neutron capture therapy of brain tumors
11. Recent advances in liposomal drug-delivery systems
12. 3]: Synthesis and liposomal delivery to murine tumors
13. Parameters affecting the immunogenicity of a liposome-associated synthetic hexapeptide antigen
14. Targeting folate receptor with folate linked to extremities of poly(ethylene glycol)-grafted liposomes: In vitro studies
15. Trophoblast and ovarian cancer antigen LK26. Sensitivity and specificity in immunopathology and molecular identification as a folate-binding protein
16. Receptor-specific delivery of liposomes via folate-PEG-chol
17. Radiation dose heterogeneity in receptor and antigen mediated boron neutron capture therapy
18. New horizon for therapy based on the boron neutron capture reaction
19. Liposomes as drug delivery vehicles for boron agents
20. Liposomes bearing poly(ethylene glycol)-coupled transferrin with intracellular targeting property to the solid tumors in vivo
21. Physical-chemistry characteristics and biodistribution of poly(ethylene glycol)-coated liposomes using poly(oxyethylene) cholesteryl ether
22. Optimization of drug loading procedures and characterization of liposomal formulations of two novel agents intended for boron neutron capture therapy (BNCT)
23. Delivery of macromolecules into living cells: A method that exploits folate receptor endocytosis
24. Delivery of liposomes to cultured KB cells via folate receptor-mediated endocytosis
25. Folate-mediated tumor cell targeting of liposome-entrapped doxorubicin in vitro
26. Folate-targeted liposomes for drug delivery
27. 10BSH entrapped transferrin-PEG-liposome to boron neutron-capture therapy (BNCT) for solid tumor
28. A new concept for macromolecular therapeutics in cancer chemotherapy: Mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs
29. Liposomal formulations containing sodium mercaptoundecahydrododecaborate (BSH) for boron neutron capture therapy
30. Current clinical paradigms in melanoma BNCT
31. Liposomes encapsulating anthracyclines: New therapeutic horizons
32. Catecholamine uptake and concentration by liposomes maintaining pH gradients
33. Immunoliposomes for cancer treatment
34. Expression and functional characterization of the beta-isoform of the folate receptor on CD34(+) cells
35. Folate-mediated targeting of therapeutic and imaging agents to cancers
36. Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Physiologic and clinical implications
37. Model studies directed toward the boron neutron-capture therapy of cancer: Boron delivery to murine tumors with liposomes
38. The rationale and requirements for the development of boron neutron capture therapy of brain tumors
39. Colorimetric determination of phospholipids with ammonium ferrothiocyanate
40. Targeted drug delivery via the folate receptor
41. In vivo evaluation of phosphorous-containing derivatives of dodecahydro- closo-dodecaborate for boron neutron capture therapy of gliomas and sarcomas
42. Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues
43. Sterically stabilized liposomes
44. Tumor growth suppression by boron neutron capture therapy using PEG-liposomal boron delivery in vivo
45. Inhibition of human pancreatic cancer growth in nude mice by boron neutron capture therapy
46. Boron neutron capture therapy (BNCT) of brain tumors: Convection enhanced delivery of boronated epidermal growth factor to EGF receptor positive gliomas
47. Enhanced survival of glioma bearing rats following boron neutron capture therapy with blood-brain barrier disruption and intracarotid injection of boronophenylalanine
48. Boron neutron capture therapy of brain tumors: Enhanced survival following intracarotid injection of sodium borocaptate with or without blood-brain barrier disruption
49. Synthesis and biological evaluation of boron-containing polyamines as potential agents for neutron capture therapy of brain tumors